What is MED's health score?

MEDIFAST INC (MED) has a TradeApes health score of 43 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MED's estimated fair value?

Based on our 5-year discounted cash flow model, MEDIFAST INC's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is MED undervalued or overvalued?

Our model currently rates MED as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for MED... Refresh in a moment for the full analysis.

MEDIFAST INC (MED)

Consumer Defensive Undervalued low weak

$12.1

Updated: 2026-06-06

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

40 Weak

Relative Value

40 Weak

Capital Allocation

55 Mixed

Risk

80 Strong

Key Findings

+ Strong liquidity — current assets more than 2× current liabilities

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.